Search

Results: 1

Cover Image for Whole-blood Point-of-Care Activated Partial Thromboplastin Time Ratio (APR) is not Accurate Enough to Monitor Heparin Therapy in Patients with Severe Respiratory Failure Secondary to SARS-Cov-2 Infection Supported with Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO).

Whole-blood Point-of-Care Activated Partial Thromboplastin Time Ratio (APR) is not Accurate Enough to Monitor Heparin Therapy in Patients with Severe Respiratory Failure Secondary to SARS-Cov-2 Infection Supported with Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO).

Daniel Aston, Martin Besser, Ben Goddard, Nicholas Maggs, Hassan Ahmed, Florian Falter

Jan 04, 2023

SARS-CoV-2 Anticoagulants Coagulation heparins Humans Partial Thromboplastin Time Heparin Extracorporeal membrane oxygenation Point-of-Care Systems covid-19 SARS-CoV-2 Anticoagulants Respiratory Insufficiency Retrospective Studies

Published by: